Outpatient Surgery Magazine

Game Changers in Surgery - June 2018 - Subscribe to Outpatient Surgery Magazine

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://outpatientsurgery.uberflip.com/i/993266

Contents of this Issue

Navigation

Page 36 of 39

2. VCF patients' propensity-adjusted mortality risk was 4 percent greater between 2010 and 2014, compared to VCF patients' risk in the 2005 to 2009 time period (p<0.001). 3. At one year, cardiac complications and pneumonia were associated with at least 10 percent greater morbidity risk for NSM patients compared to BKP patients. Dr. Ong and his team did not see a higher prevalence of baseline co- morbidities in NSM patients compared to augmentation patients. 4. The length of stay for NSM patients clocked in at 0.2 days shorter than the BKP patients. However, about twice as many BKP patients were discharged home. 6 The following limitations apply to the 2017 study and are generally applicable to the other retrospective claims analyses: • Retrospective database analyses may be prone to selection bias 6-11 • Confounding by other unmeasured selection bias or variables not considered in the analysis is possible 6-11 • Causality of treatment received with mortality outcomes cannot be demonstrated 6-11 nor can causality of the sham trial publications to increased mortality found in the 5-year period following 6 • Cause of death not available in database 6-11 • Was not possible to evaluate all possible co- morbidities 8,10 • Outcomes such as pain and quality of life were not available 6-11 Dr. Hirsch agrees with the conclusion: "We found that there has been an increase in the mortality rate of all VCF patients in the second group [2010 to 2014] compared to the first group [2005 to 2009]." Impact on payers, referrers and providers The 2017 analysis' findings align with the majority of the five above studies on mortality and VCF patients published after the 2009 'sham' studies. "[The study] will certainly help strengthen our overall data collectively and protect our positive coverage policies that are in place," says Jeff Cambra, general manager of Medtronic. "This will likely be valuable data, especially for treating and referring physicians." Dr. Hirsch believes this study will provoke a discussion among referring clinicians about the best evidence-based treatment for their patients. "These procedures really do provide meaningful benefits to patients," he says. "I manage many patients with conservative therapy; there's a role for that. What I object to is when patients call their doctors and the doctor says there is nothing to do [for treatment]." About Balloon Kyphoplasty - Indication and Risk Statement Kyphon™ Balloon Kyphoplasty is a minimally invasive procedure for the treatment of pathological fractures of the vertebral body due to osteoporosis, cancer or benign lesion. The complication rate with Kyphon Balloon Kyphoplasty has been demon - strated to be low. There are risks associated with the procedure (e.g., cement extravasation), including serious complications, and through rare, some of which may be fatal. Risks of acrylic bone cements include cement leakage, which may cause tissue damage, nerve or circulatory problems, and other serious adverse events, such as: Cardiac arrest, Cerebrovascular accident, Myocardial infarction, Pulmonary embolism and Cardiac embolism. For complete information regarding indications for use, contraindications, warnings, precautions, adverse events, and methods of use, please reference the devices' Instructions for Use included with the product. Sponsored by SPECIAL ADVERTISING SUPPLEMENT J U N E 2 0 1 8 • O U T PAT I E N TS U R G E R Y. N E T • 3 7

Articles in this issue

Archives of this issue

view archives of Outpatient Surgery Magazine - Game Changers in Surgery - June 2018 - Subscribe to Outpatient Surgery Magazine